• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Rap_GAP 结构域通过 mTOR 信号通路促进人肝癌肿瘤抑制。

Rap_GAP Domain of Contributes to Tumor Suppression Through mTOR Signaling in Human Hepatocellular Carcinoma.

机构信息

Department of Hepatobiliary and Pancreatic Surgery, The Second Hospital of Jilin University, Changchun, P.R. China.

Department of Orthopedic, The Second Hospital of Jilin University, Changchun, P.R. China.

出版信息

DNA Cell Biol. 2022 Feb;41(2):215-224. doi: 10.1089/dna.2021.0769.

DOI:10.1089/dna.2021.0769
PMID:35143341
Abstract

Hepatocellular carcinoma (HCC) is an aggressive disease with a high degree of tumor heterogeneity. Genetic lesions of mTOR-related genes, including and hyperactivation of mTOR signaling, are common in HCC. However, the association of genetic alterations with hepatocarcinogenesis remains unclear. In this study, continuous truncating mutations occurred within or upstream of the Rap_GAP domain in clinical HCC samples. To elucidate whether hyperactivation of mTOR signaling in HCC is caused by truncating mutations, HCC cell models carrying the deletion (CRISPR/Cas9) or the truncating mutation (mutagenesis) were established. Our findings showed that either deletion or mutant could lead to loss-of-function and hyperactivation of mTOR signaling. Furthermore, hyperactivation of mTOR signaling was relieved by rapamycin. Immunohistochemistry of clinical samples confirmed frequent loss in HCC. Thus, our study revealed that genetic alterations cause loss of function and result in the hyperactivation of mTOR, and high frequency of truncating mutations around RAP_GAP domain may be one of the reasons for the hyperactivation of mTOR in HCC patients.

摘要

肝细胞癌 (HCC) 是一种侵袭性疾病,具有高度的肿瘤异质性。mTOR 相关基因的遗传病变,包括 和 mTOR 信号的过度激活,在 HCC 中很常见。然而,遗传改变与肝癌发生的关系尚不清楚。在这项研究中,临床 HCC 样本中 Rap_GAP 结构域内或其上游发生连续截断突变。为了阐明 HCC 中 mTOR 信号的过度激活是否是由 截断突变引起的,建立了携带 缺失(CRISPR/Cas9)或 截断突变(诱变)的 HCC 细胞模型。我们的研究结果表明,无论是 缺失还是 突变都可能导致 功能丧失和 mTOR 信号的过度激活。此外,雷帕霉素可缓解 mTOR 信号的过度激活。临床样本的免疫组化证实 HCC 中 经常缺失。因此,我们的研究表明遗传改变导致 功能丧失,并导致 mTOR 的过度激活,而 RAP_GAP 结构域周围 截断突变的高频可能是 HCC 患者中 mTOR 过度激活的原因之一。

相似文献

1
Rap_GAP Domain of Contributes to Tumor Suppression Through mTOR Signaling in Human Hepatocellular Carcinoma.Rap_GAP 结构域通过 mTOR 信号通路促进人肝癌肿瘤抑制。
DNA Cell Biol. 2022 Feb;41(2):215-224. doi: 10.1089/dna.2021.0769.
2
mutations define a molecular subset of HCC with aggressive behaviour and treatment implication.突变定义了具有侵袭性生物学行为及治疗意义的肝癌分子亚群。
Gut. 2017 Aug;66(8):1496-1506. doi: 10.1136/gutjnl-2016-312734. Epub 2016 Dec 14.
3
Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus.结节性硬化复合物2(TSC2)缺失在肝细胞癌中很常见,并可预测对mTORC1抑制剂依维莫司的反应。
Mol Cancer Ther. 2015 May;14(5):1224-35. doi: 10.1158/1535-7163.MCT-14-0768. Epub 2015 Feb 27.
4
Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinoma.在肝细胞癌中,VEPH1功能受抑制通过削弱TSC1/TSC2的结合来激活mTORC1信号通路。
J Hepatol. 2020 Dec;73(6):1446-1459. doi: 10.1016/j.jhep.2020.06.027. Epub 2020 Jun 28.
5
Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling.白细胞介素-6刺激的前颗粒蛋白表达通过激活mTOR信号传导促进肝癌细胞的恶性增殖。
Sci Rep. 2016 Feb 16;6:21260. doi: 10.1038/srep21260.
6
Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma.结节性硬化复合物2功能丧失与子宫内膜癌中雷帕霉素哺乳动物靶标信号通路的激活
Clin Cancer Res. 2008 May 1;14(9):2543-50. doi: 10.1158/1078-0432.CCR-07-0321.
7
A large deletion in TSC2 causes tuberous sclerosis complex by dysregulating PI3K/AKT/mTOR signaling pathway.一个 TSC2 的大片段缺失通过调控 PI3K/AKT/mTOR 信号通路引起结节性硬化症。
Gene. 2024 May 30;909:148312. doi: 10.1016/j.gene.2024.148312. Epub 2024 Feb 25.
8
Advanced sporadic renal epithelioid angiomyolipoma: case report of an extraordinary response to sirolimus linked to TSC2 mutation.高级散发性肾脏上皮样血管平滑肌脂肪瘤:与 TSC2 突变相关的西罗莫司引起的显著反应的病例报告。
BMC Cancer. 2018 May 15;18(1):561. doi: 10.1186/s12885-018-4467-6.
9
p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma.p53单倍体不足和mTOR信号传导增加定义了侵袭性肝细胞癌的一个亚组。
J Hepatol. 2021 Jan;74(1):96-108. doi: 10.1016/j.jhep.2020.07.036. Epub 2020 Jul 29.
10
Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer.评估 Hsp90 和 mTOR 抑制剂作为治疗 TSC1/TSC2 缺陷型癌症的潜在药物。
PLoS One. 2021 Apr 23;16(4):e0248380. doi: 10.1371/journal.pone.0248380. eCollection 2021.